S
Sherman Baker
Researcher at Virginia Commonwealth University
Publications - 9
Citations - 1422
Sherman Baker is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Lung cancer & Guideline. The author has an hindex of 7, co-authored 9 publications receiving 1129 citations. Previous affiliations of Sherman Baker include Indiana University.
Papers
More filters
Journal ArticleDOI
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A. Masters,Sarah Temin,Christopher G. Azzoli,Giuseppe Giaccone,Sherman Baker,Julie R. Brahmer,Peter M. Ellis,Ajeet Gajra,Nancy Rackear,Joan H. Schiller,Thomas J. Smith,John R. Strawn,David Trent,David H. Johnson +13 more
TL;DR: This guideline update reflects changes in evidence since the previous guideline and recommends combination cytotoxic chemotherapy is recommended, guided by histology, with early concurrent palliative care.
Journal ArticleDOI
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Nasser H. Hanna,Bryan J. Schneider,Sarah Temin,Sherman Baker,Julie R. Brahmer,Peter M. Ellis,Laurie E. Gaspar,Laurie E. Gaspar,Rami Y. Haddad,Paul J. Hesketh,Dharamvir Jain,Ishmael Jaiyesimi,David H. Johnson,Natasha B. Leighl,Tanyanika Phillips,Gregory J. Riely,Andrew G. Robinson,Rafael Rosell,Joan H. Schiller,Navneet Singh,David R. Spigel,Janis O. Stabler,Joan Tashbar,Gregory A. Masters +23 more
TL;DR: This guideline update reflects changes in evidence since the previous guideline update and is conditional on the basis of histology, PD-L1 status, and/or the presence of contraindications.
Journal ArticleDOI
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Christopher G. Azzoli,Sarah Temin,Timothy Aliff,Sherman Baker,Julie R. Brahmer,David H. Johnson,Janessa L. Laskin,Gregory A. Masters,Daniel T. Milton,Luke Nordquist,William Pao,David G. Pfister,Steven Piantadosi,Joan H. Schiller,Reily Smith,Thomas J. Smith,John R. Strawn,David Trent,Giuseppe Giaccone +18 more
TL;DR: This document updates one recommendation of the ASCO Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer (NSCLC) regarding switch maintenance chemotherapy.
Journal ArticleDOI
Depressive symptoms in lung cancer Patients and their family caregivers and the influence of family environment
TL;DR: This study investigated depressive symptomatology in lung cancer patients and their identified caregiver and found that depression in patients with a history of lung cancer and a caregiver diagnosis is connected.
Journal ArticleDOI
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)
Maria Q. Baggstrom,Mark A. Socinski,Xiaofei Wang,Lin Gu,Thomas E. Stinchcombe,Martin J. Edelman,Sherman Baker,Josephine Feliciano,Paul J. Novotny,Olwen Hahn,Jeffrey Crawford,Everett E. Vokes +11 more
TL;DR: Investigation of maintenance sunitinib after first‐line chemotherapy for stage IIIB/IV NSCLC found it was safe and improved PFS as maintenance therapy but had no impact on overall survival.